{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:59:40Z","timestamp":1792112380949,"version":"4.4.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>Venous thromboembolism (VTE), which includes deep vein thrombosis and pulmonary embolism, is a common and potentially severe complication associated with ovarian cancer. This cancer, typically identified at a later stage, produces a hypercoagulable setting due to both inherent tumor characteristics and external treatment-induced influences. The interaction of pro-inflammatory cytokines, the expression of tissue factor (TF), activation of platelets, and mechanical obstruction of veins leads to a significant occurrence of thrombotic events. These occurrences not only deteriorate outcomes but also complicate treatment choices and elevate the strain on healthcare systems. Various risk factors lead to the increased VTE risk in ovarian cancer patients, such as significant tumor burden, cytoreductive surgery, chemotherapy, lack of mobility, and associated health issues like obesity or a history of thrombosis. The clinical signs of VTE may be subtle and nonspecific, necessitating a high level of clinical suspicion and careful application of imaging techniques for prompt diagnosis. Laboratory indicators like D-dimer and platelet count can provide helpful information but do not have specificity in patients with cancer. The recurrence rate of VTE in ovarian cancer is elevated, and its manifestation correlates with markedly lower overall survival. Management approaches emphasize prevention, prompt identification, and ongoing anticoagulant therapy. Low-molecular-weight heparins continue to be the standard treatment for numerous patients, while direct oral anticoagulants are becoming more popular because of their convenience and similar effectiveness. Thromboprophylaxis is especially important in the perioperative environment and throughout hospitalization.<\/jats:p>","DOI":"10.1097\/ms9.0000000000004192","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T14:00:09Z","timestamp":1763733609000},"page":"8587-8596","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Venous thromboembolism in ovarian cancer: pathophysiology, risk, and management"],"prefix":"10.1097","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4538-0161","authenticated-orcid":false,"given":"Emmanuel Ifeanyi","family":"Obeagu","sequence":"first","affiliation":[{"name":"Department of Biomedical and Laboratory Science, Africa University, Mutare, Zimbabwe"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"R1-20260319","doi-asserted-by":"crossref","first-page":"581\u201387","DOI":"10.1097\/IGC.0000000000000912","article-title":"Incidence of venous thromboembolism by type of gynecologic malignancy and surgical modality in the national surgical quality improvement program","volume":"27","author":"Graul","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"R2-20260319","doi-asserted-by":"crossref","first-page":"2374716","DOI":"10.1155\/2020\/2374716","article-title":"Meta-analysis of VTE risk: ovarian cancer patients by stage, histology, cytoreduction, and ascites at diagnosis","volume":"2020","author":"Weeks","year":"2020","journal-title":"Obstet Gynecol Int"},{"key":"R3-20260319","doi-asserted-by":"crossref","first-page":"101375","DOI":"10.1016\/j.mtbio.2024.101375","article-title":"Emerging advances in drug delivery systems (DDSs) for optimizing cancer complications","volume":"30","author":"Li","year":"2024","journal-title":"Mater Today Bio"},{"key":"R4-20260319","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/diseases11040132","article-title":"C-reactive protein: pathophysiology, diagnosis, false test results and a novel diagnostic algorithm for clinicians","volume":"11","author":"Mouliou","year":"2023","journal-title":"Diseases"},{"key":"R5-20260319","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.3390\/cancers15215293","article-title":"Cancer-associated abdominal vein thrombosis","volume":"15","author":"Muscat-Baron","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R6-20260319","doi-asserted-by":"crossref","first-page":"4839\u201347","DOI":"10.1200\/JCO.2009.22.3271","article-title":"Assessing risk of venous thromboembolism in the patient with cancer","volume":"27","author":"Khorana","year":"2009","journal-title":"J Clin Oncol"},{"key":"R7-20260319","doi-asserted-by":"crossref","first-page":"167\u201371","DOI":"10.1016\/j.ygyno.2023.01.012","article-title":"Assessing the need for venous thromboembolism prophylaxis at the time of neoadjuvant chemotherapy for ovarian cancer: a literature review","volume":"170","author":"Moufarrij","year":"2023","journal-title":"Gynecol Oncol"},{"key":"R8-20260319","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","article-title":"International Initiative on Thrombosis and Cancer (ITAC) advisory panel. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19","volume":"23","author":"Farge","year":"2022","journal-title":"Lancet Oncol"},{"key":"R9-20260319","doi-asserted-by":"crossref","first-page":"199\u2013207","DOI":"10.1634\/theoncologist.2016-0214","article-title":"Cancer and venous thromboembolic disease: a review","volume":"22","author":"Donnellan","year":"2017","journal-title":"Oncologist"},{"key":"R10-20260319","doi-asserted-by":"crossref","first-page":"126\u201333","DOI":"10.1002\/hon.785","article-title":"The pathogenesis of venous thromboembolism in cancer: emerging links with tumour biology","volume":"24","author":"Winter","year":"2006","journal-title":"Hematol Oncol"},{"key":"R11-20260319","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3390\/cells14070488","article-title":"The role of inflammation in cancer: mechanisms of tumor initiation, progression, and metastasis","volume":"14","author":"Nishida","year":"2025","journal-title":"Cells"},{"key":"R12-20260319","first-page":"895\u2013909","article-title":"Inflammation and immune escape in ovarian cancer: pathways and therapeutic opportunities","volume":"18","author":"Liu","year":"2025","journal-title":"J Inflamm Res"},{"key":"R13-20260319","doi-asserted-by":"crossref","first-page":"9\u201316","DOI":"10.1038\/s41416-020-0875-x","article-title":"The untapped potential of ascites in ovarian cancer research and treatment","volume":"123","author":"Ford","year":"2020","journal-title":"Br J Cancer"},{"key":"R14-20260319","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.3390\/cancers13174318","article-title":"Malignant ascites in ovarian cancer: cellular, acellular, and biophysical determinants of molecular characteristics and therapy response","volume":"13","author":"Rickard","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R15-20260319","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3390\/cancers15041282","article-title":"Interactions between platelets and tumor microenvironment components in ovarian cancer and their implications for treatment and clinical outcomes","volume":"15","author":"Oncul","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R16-20260319","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1002\/mco2.350","article-title":"The role of platelets in the regulation of tumor growth and metastasis: the mechanisms and targeted therapy","volume":"4","author":"Liao","year":"2023","journal-title":"MedComm"},{"key":"R17-20260319","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.3390\/jcm9082467","article-title":"Prevention of venous thromboembolism in 2020 and beyond","volume":"9","author":"Nicholson","year":"2020","journal-title":"J Clin Med"},{"key":"R18-20260319","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3390\/cancers10100380","article-title":"Cancer-associated thrombosis: an overview of mechanisms, risk factors, and treatment","volume":"10","author":"Abdol Razak","year":"2018","journal-title":"Cancers (Basel)"},{"key":"R19-20260319","first-page":"129\u201335","article-title":"Thromboprophylaxis in surgical patients","volume":"46","author":"O\u2019Donnell","year":"2003","journal-title":"Can J Surg"},{"key":"R20-20260319","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1055\/a-2159-9957","article-title":"Surgery as a trigger for incident venous thromboembolism: results from a population-based case-crossover study","volume":"7","author":"Meknas","year":"2023","journal-title":"TH Open"},{"key":"R21-20260319","doi-asserted-by":"crossref","first-page":"162\u201368","DOI":"10.15386\/mpr-1372","article-title":"Association between obesity and venous thromboembolism","volume":"93","author":"Hotoleanu","year":"2020","journal-title":"Med Pharm Rep"},{"key":"R22-20260319","doi-asserted-by":"crossref","first-page":"1457280","DOI":"10.3389\/fphar.2024.1457280","article-title":"Anticoagulation approach in morbid obesity: a comprehensive review on venous thromboembolism management","volume":"15","author":"Sorodoc","year":"2024","journal-title":"Front Pharmacol"},{"key":"R23-20260319","doi-asserted-by":"crossref","first-page":"4263\u201368","DOI":"10.31557\/APJCP.2023.24.12.4263","article-title":"D-dimer, fibrinogen and tumor marker levels in patients with benign and malignant ovarian tumors","volume":"24","author":"Farzaneh","year":"2023","journal-title":"Asian Pac J Cancer Prev"},{"key":"R24-20260319","doi-asserted-by":"crossref","first-page":"1158\u201364","DOI":"10.3324\/haematol.2011.054718","article-title":"High D-dimer levels are associated with poor prognosis in cancer patients","volume":"97","author":"Ay","year":"2012","journal-title":"Haematologica"},{"key":"R25-20260319","doi-asserted-by":"crossref","first-page":"189\u201394","DOI":"10.1038\/sj.bjc.6602917","article-title":"Primary thromboprophylaxis for cancer patients with central venous catheters\u2013a reappraisal of the evidence","volume":"94","author":"Cunningham","year":"2006","journal-title":"Br J Cancer"},{"key":"R26-20260319","doi-asserted-by":"crossref","first-page":"2602\u201304","DOI":"10.1111\/jth.12023","article-title":"Subcommittee on hemostasis and malignancy of the SSC of the ISTH. Incidental venous thromboembolism in oncology patients","volume":"10","author":"Khorana","year":"2012","journal-title":"J Thromb Haemost"},{"key":"R27-20260319","doi-asserted-by":"crossref","first-page":"F1000","DOI":"10.12688\/f1000research.21347.1","article-title":"Advances in the diagnosis of acute pulmonary embolism","volume":"9","author":"Ishaaya","year":"2020","journal-title":"F1000Res"},{"key":"R28-20260319","doi-asserted-by":"crossref","first-page":"48\u201352","DOI":"10.4143\/crt.2010.42.1.48","article-title":"Diagnostic laparoscopy of patient with deep vein thrombosis before diagnosis of ovarian cancer: a case report","volume":"42","author":"Ha","year":"2010","journal-title":"Cancer Res Treat"},{"key":"R29-20260319","first-page":"129\u201338","article-title":"Pulmonary embolism, part I: epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism","volume":"18","author":"B\u0115lohl\u00e1vek","year":"2013","journal-title":"Exp Clin Cardiol"},{"key":"R30-20260319","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/diagnostics15010082","article-title":"Expert-based narrative review on Compression Ultrasonography (CUS) for diagnosis and follow-up of Deep Venous Thrombosis (DVT)","volume":"15","author":"D\u2019Oria","year":"2025","journal-title":"Diagnostics (Basel)"},{"key":"R31-20260319","doi-asserted-by":"crossref","first-page":"493\u2013507","DOI":"10.21037\/cdt.2016.12.06","article-title":"Advanced imaging in acute and chronic deep vein thrombosis","volume":"6","author":"Karande","year":"2016","journal-title":"Cardiovasc Diagn Ther"},{"key":"R32-20260319","doi-asserted-by":"crossref","first-page":"1277\u201387","DOI":"10.3324\/haematol.2018.209114","article-title":"CAT-prediction collaborators. The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis","volume":"104","author":"Mulder","year":"2019","journal-title":"Haematologica"},{"key":"R33-20260319","doi-asserted-by":"crossref","first-page":"101156","DOI":"10.1016\/j.gore.2023.101156","article-title":"Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer","volume":"46","author":"Piver","year":"2023","journal-title":"Gynecol Oncol Rep"},{"key":"R34-20260319","doi-asserted-by":"crossref","first-page":"279\u201385","DOI":"10.1007\/s13193-021-01281-0","article-title":"A prospective observational study to determine rate of thromboprophylaxis in oncology patients undergoing abdominal or pelvic surgery","volume":"12","author":"Shrikhande","year":"2021","journal-title":"Indian J Surg Oncol"},{"key":"R35-20260319","doi-asserted-by":"crossref","first-page":"171\u201389","DOI":"10.2147\/JBM.S411520","article-title":"The role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: review by middle East and North African experts","volume":"15","author":"Bazarbashi","year":"2024","journal-title":"J Blood Med"},{"key":"R36-20260319","doi-asserted-by":"crossref","first-page":"41\u201366","DOI":"10.1007\/s12325-022-02333-9","article-title":"Risk and management of bleeding complications with direct oral anticoagulants in patients with atrial fibrillation and venous thromboembolism: a narrative review","volume":"40","author":"Ballestri","year":"2023","journal-title":"Adv Ther"},{"key":"R37-20260319","doi-asserted-by":"crossref","first-page":"1551\u201358","DOI":"10.1681\/ASN.2020121806","article-title":"Role of platelets in chronic kidney disease","volume":"32","author":"Jain","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"R38-20260319","doi-asserted-by":"crossref","first-page":"155\u201370","DOI":"10.2215\/CJN.04100321","article-title":"Platelet abnormalities in CKD and their implications for antiplatelet therapy","volume":"17","author":"Baaten","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"R39-20260319","doi-asserted-by":"crossref","first-page":"102194","DOI":"10.1016\/j.eclinm.2023.102194","article-title":"The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis: a systematic review and meta-analysis","volume":"64","author":"van Hylckama Vlieg","year":"2023","journal-title":"EClinicalMedicine"},{"key":"R40-20260319","doi-asserted-by":"crossref","first-page":"51\u201356","DOI":"10.4137\/BIC.S30347","article-title":"Microparticles as biomarkers of blood coagulation in cancer","volume":"7","author":"Nomura","year":"2015","journal-title":"Biomark Cancer"},{"key":"R41-20260319","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.3390\/cancers15102697","article-title":"Direct-acting oral anticoagulant therapy in cancer patients-A review","volume":"15","author":"G\u00f3rnicki","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R42-20260319","doi-asserted-by":"crossref","first-page":"1222209","DOI":"10.3389\/fphar.2023.1222209","article-title":"Editorial: ovarian cancer-targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more","volume":"14","author":"Wang","year":"2023","journal-title":"Front Pharmacol"},{"key":"R43-20260319","doi-asserted-by":"crossref","first-page":"1535235","DOI":"10.3389\/fonc.2025.1535235","article-title":"Ovarian cancer targeted therapy: current landscape and future challenges","volume":"15","author":"Wang","year":"2025","journal-title":"Front Oncol"},{"key":"R44-20260319","doi-asserted-by":"crossref","first-page":"101551","DOI":"10.1016\/j.gore.2024.101551","article-title":"The use of direct oral anticoagulants (DOACs) for thromboprophylaxis during neoadjuvant chemotherapy and after interval debulking surgery in ovarian cancer patients - Maximizing prevention of venous thromboembolism (VTE)","volume":"56","author":"Michael Straughn","year":"2024","journal-title":"Gynecol Oncol Rep"},{"key":"R45-20260319","doi-asserted-by":"crossref","first-page":"927\u201374","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv"},{"key":"R46-20260319","doi-asserted-by":"crossref","first-page":"1420012","DOI":"10.3389\/fmed.2024.1420012","article-title":"Advancements in the interventional therapy and nursing care on deep vein thrombosis in the lower extremities","volume":"11","author":"Jia","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"R47-20260319","doi-asserted-by":"crossref","first-page":"e000680","DOI":"10.1136\/bmjoq-2019-000680","article-title":"Multidisciplinary, patient-centred approach to improving compliance with venous thromboembolism (VTE) prophylaxis in a district general hospital","volume":"9","author":"Nana","year":"2020","journal-title":"BMJ Open Qual"},{"key":"R48-20260319","first-page":"100082","article-title":"Transparency in the Reporting of Artificial Intelligence \u2013 the TITAN Guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000004192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:06:07Z","timestamp":1773936367000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000004192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000004192","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"2025-07-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}